CVS BOYCOTT SURVEY

Thank you for your interest in our survey on CVS Health's plan to limit the dosage and supply of opioid pain medication to customers enrolled in its pharmacy benefit management program.

Starting February 1, 2018, CVS Caremark will only provide a 7-day supply of opioids for acute, short term pain. All opioid prescriptions -- for both acute and chronic pain -- will also be limited to no more than 90mg morphine equivalent units.

2,528 people participated in our online survey between September 28 and October 12, 2017. The vast majority of respondents (85%) identified themselves as pain patients.

Chart_Q1_171014.png
Chart_Q3_171014.png
Chart_Q4_171014.png